205 related articles for article (PubMed ID: 22366758)
1. N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death.
Ofengeim D; Chen YB; Miyawaki T; Li H; Sacchetti S; Flannery RJ; Alavian KN; Pontarelli F; Roelofs BA; Hickman JA; Hardwick JM; Zukin RS; Jonas EA
Nat Neurosci; 2012 Feb; 15(4):574-80. PubMed ID: 22366758
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Bcl-xL prevents pro-death actions of ΔN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity.
Park HA; Licznerski P; Mnatsakanyan N; Niu Y; Sacchetti S; Wu J; Polster BM; Alavian KN; Jonas EA
Cell Death Differ; 2017 Nov; 24(11):1963-1974. PubMed ID: 28777375
[TBL] [Abstract][Full Text] [Related]
3. Bcl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission.
Hickman JA; Hardwick JM; Kaczmarek LK; Jonas EA
J Neurophysiol; 2008 Mar; 99(3):1515-22. PubMed ID: 18160428
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial fragmentation and neuronal cell death in response to the Bcl-2/Bcl-x(L)/Bcl-w antagonist ABT-737.
Young KW; Piñón LG; Dhiraj D; Twiddy D; Macfarlane M; Hickman J; Nicotera P
Neuropharmacology; 2010 Jun; 58(8):1258-67. PubMed ID: 20307556
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons.
Miyawaki T; Mashiko T; Ofengeim D; Flannery RJ; Noh KM; Fujisawa S; Bonanni L; Bennett MV; Zukin RS; Jonas EA
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4892-7. PubMed ID: 18347331
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Bcl-xl protects septal neurons from prolonged hypoglycemia and from acute ischemia-like stress.
Panickar KS; Nonner D; Barrett JN
Neuroscience; 2005; 135(1):73-80. PubMed ID: 16111822
[TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737.
Stauffer SR
Curr Top Med Chem; 2007; 7(10):961-5. PubMed ID: 17508927
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.
Mérino D; Khaw SL; Glaser SP; Anderson DJ; Belmont LD; Wong C; Yue P; Robati M; Phipson B; Fairlie WD; Lee EF; Campbell KJ; Vandenberg CJ; Cory S; Roberts AW; Ludlam MJ; Huang DC; Bouillet P
Blood; 2012 Jun; 119(24):5807-16. PubMed ID: 22538851
[TBL] [Abstract][Full Text] [Related]
9. Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.
Gautier F; Guillemin Y; Cartron PF; Gallenne T; Cauquil N; Le Diguarher T; Casara P; Vallette FM; Manon S; Hickman JA; Geneste O; Juin P
Mol Cell Biol; 2011 Feb; 31(4):832-44. PubMed ID: 21173168
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase.
Alavian KN; Li H; Collis L; Bonanni L; Zeng L; Sacchetti S; Lazrove E; Nabili P; Flaherty B; Graham M; Chen Y; Messerli SM; Mariggio MA; Rahner C; McNay E; Shore GC; Smith PJ; Hardwick JM; Jonas EA
Nat Cell Biol; 2011 Sep; 13(10):1224-33. PubMed ID: 21926988
[TBL] [Abstract][Full Text] [Related]
11. A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo.
Shoemaker AR; Oleksijew A; Bauch J; Belli BA; Borre T; Bruncko M; Deckwirth T; Frost DJ; Jarvis K; Joseph MK; Marsh K; McClellan W; Nellans H; Ng S; Nimmer P; O'Connor JM; Oltersdorf T; Qing W; Shen W; Stavropoulos J; Tahir SK; Wang B; Warner R; Zhang H; Fesik SW; Rosenberg SH; Elmore SW
Cancer Res; 2006 Sep; 66(17):8731-9. PubMed ID: 16951189
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.
Oakes SR; Vaillant F; Lim E; Lee L; Breslin K; Feleppa F; Deb S; Ritchie ME; Takano E; Ward T; Fox SB; Generali D; Smyth GK; Strasser A; Huang DC; Visvader JE; Lindeman GJ
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2766-71. PubMed ID: 21768359
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect.
Li M; Chen F; Clifton N; Sullivan DM; Dalton WS; Gabrilovich DI; Nefedova Y
Mol Cancer Ther; 2010 Dec; 9(12):3200-9. PubMed ID: 21159606
[TBL] [Abstract][Full Text] [Related]
14. Bcl-x(L) blocks a mitochondrial inner membrane channel and prevents Ca2+ overload-mediated cell death.
Tornero D; Posadas I; Ceña V
PLoS One; 2011; 6(6):e20423. PubMed ID: 21674052
[TBL] [Abstract][Full Text] [Related]
15. Zinc-dependent multi-conductance channel activity in mitochondria isolated from ischemic brain.
Bonanni L; Chachar M; Jover-Mengual T; Li H; Jones A; Yokota H; Ofengeim D; Flannery RJ; Miyawaki T; Cho CH; Polster BM; Pypaert M; Hardwick JM; Sensi SL; Zukin RS; Jonas EA
J Neurosci; 2006 Jun; 26(25):6851-62. PubMed ID: 16793892
[TBL] [Abstract][Full Text] [Related]
16. Bcl-xL is an oncogenic driver in colorectal cancer.
Scherr AL; Gdynia G; Salou M; Radhakrishnan P; Duglova K; Heller A; Keim S; Kautz N; Jassowicz A; Elssner C; He YW; Jaeger D; Heikenwalder M; Schneider M; Weber A; Roth W; Schulze-Bergkamen H; Koehler BC
Cell Death Dis; 2016 Aug; 7(8):e2342. PubMed ID: 27537525
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
18. Contribution of downregulation of L-type calcium currents to delayed neuronal death in rat hippocampus after global cerebral ischemia and reperfusion.
Li XM; Yang JM; Hu DH; Hou FQ; Zhao M; Zhu XH; Wang Y; Li JG; Hu P; Chen L; Qin LN; Gao TM
J Neurosci; 2007 May; 27(19):5249-59. PubMed ID: 17494711
[TBL] [Abstract][Full Text] [Related]
19. Late calcium EDTA rescues hippocampal CA1 neurons from global ischemia-induced death.
Calderone A; Jover T; Mashiko T; Noh KM; Tanaka H; Bennett MV; Zukin RS
J Neurosci; 2004 Nov; 24(44):9903-13. PubMed ID: 15525775
[TBL] [Abstract][Full Text] [Related]
20. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737.
Okumura K; Huang S; Sinicrope FA
Clin Cancer Res; 2008 Dec; 14(24):8132-42. PubMed ID: 19088028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
